Services
Growth Innovation Operations
Cases
Insights
AGP Insights Eco Insiders Podcast
About
Contact
EN
中文

Personal Information

Upload Avatar (500 x 500)
Changjun Cao
{'en': 'Phone: 027-67812888, 027-67812999', 'zh': '电话：027-67812888、027-67812999', 'de': 'Telefon: 027-67812888, 027-67812999'}
Chinese
Hubei

Academic Information

Wuhan University
Medical School
  • Member of the Hubei Province Neurosurgery Branch of the Medical Association
  • Member of the Wuhan Medical Association Neurosurgery Branch
  • Vice Leader of the Neuroendoscopy Group of the Wuhan Medical Association Neurosurgery Branch

Research

Skull base tumors (pituitary tumors, acoustic neuromas, skull base meningiomas) and cerebrovascular disease micro and endoscopic surgical treatment
Keywords
Skull Base Tumors Pituitary Tumors Acoustic Neuromas Skull Base Meningiomas Cerebrovascular Disease Microsurgery Endoscopic Surgery Neurosurgery Tumor Treatment Surgical Treatment
Related Professors
Li Zhiqiang - Wuhan University
Area of Focus
Brain Gliomas | Metastatic Tumors | Comprehensive Treatment | Acoustic Neuromas | Microsurgery | Neurosurgery | Multimodal Mr Imaging | Neuronavigation | Intraoperative Awakening | Intraoperative Electrical Stimulation
Zhongwei Xiong - Wuhan University
Area of Focus
Skull Base Tumors | Pituitary Tumors | Acoustic Neuromas | Skull Base Meningiomas | Cerebrovascular Disease | Microsurgery | Endoscopic Surgery | Neurosurgery | Tumor Treatment | Surgical Techniques
Yihui Ma - Wuhan University
Area of Focus
Cerebrovascular Disease | Brain Tumors | Cranial Trauma | Cerebral Hemorrhage | Microsurgery | Interventional Diagnosis | Intracranial Aneurysms | Vascular Malformations | Clinical Treatment | Basic Research
View All
© 2015-2024 Asia Growth Partners Limited | Privacy Policy

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.